IFNAR2 and COVID-19: A separate study reported that higher levels of the soluble receptor (sIFNAR2) were observed in survivors of COVID-19 compared to the group of non-survivors, which was not associated with the scrutinized IFNAR2 genetic variants (Fricke-Galindo et al., 2022).